BioSpace News Archive

Black Diamond Therapeutics, Inc. provided a corporate update outlining clinical development plans and anticipated corporate milestones for 2024.

Third Harmonic Bio, Inc. today announced the appointment of Christopher Murphy as Chief Financial and Business Officer.

Jnana Therapeutics today announced that Joanne Kotz, Ph.D., Co-founder and Chief Executive Officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 8, 2024 at 5:30 p.m. PT.

Portage Biotech Inc. today announced the outcome from the company’s comprehensive review of its pipeline in the context of the current capital raising market conditions.

CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated, localized biologics, today announced its 2024 company priorities and anticipated milestones for its wholly-owned and partnered pipeline.

Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated cancers that impact patients worldwide, today provided a clinical update, including its roadmap for advancing Nana-val’s clinical development in 2024.

Ocuphire Pharma, Inc. today announced it has received agreement from the U.S. Food and Drug Administration (FDA) under a Special Protocol Assessment (SPA) for the clinical trial protocol and planned statistical analysis of the LYNX-2 Phase 3 trial to evaluate phentolamine ophthalmic solution for the proposed indication for the treatment of decreased visual acuity under dim (mesopic) light conditions.

NewAmsterdam Pharma Company N.V. today provided an update on its clinical development programs and outlined its strategic priorities for 2024.

Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative antiviral therapeutics targeting serious viral diseases, today provided an outline of the anticipated milestones and progress for its clinical pipeline during 2024.

OncoC4, Inc. today announced its participation in the 42nd Annual J.P. Morgan Healthcare Conference being held in San Francisco, California.